SCHEMBL19961698

SCHEMBL19961698

c1ccc(-n2c(-c3ccc4ccccc4c3)nc3ccncc32)cc1

nearest known ligand 0.60

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 15/20 0.60
▸ KCNH2 Q12809 2/20 0.54
▸ AOC2 O75106 2/20 0.51
▸ GRM1 Q13255 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15172080 0.91 AOC3 (0.55) AOC3KCNH2AOC2
SCHEMBL15172079 0.90 AOC3 (0.53) AOC3KCNH2AOC2
SCHEMBL19961726 0.89 RPS6KA5 (0.54) AOC3KCNH2GRM1
SCHEMBL15172076 0.88 AOC3 (0.51) AOC3KCNH2AOC2
SCHEMBL10247512 0.86 AOC3 (0.67) AOC3KCNH2
SCHEMBL8011262 0.84 ESR1 (0.57) —
SCHEMBL14506132 0.83 ESR1 (0.56) —
SCHEMBL14506131 0.83 ESR1 (0.56) —
SCHEMBL10353569 0.82 AOC3 (0.48) AOC3KCNH2AOC2
SCHEMBL15172081 0.82 AOC3 (0.46) AOC3KCNH2AOC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3660934-A1 ORGANIC LIGHT EMITTING ELEMENT CAPABLE OF DRIVING AT LOW VOLTAGE AND HAVING HIGH EFFICIENCY AND LONG LIFE CHARACTERISTICS SFC Co., Ltd. (KR) 2020-06-03 — — EP disclosed
US-20180072753-A1 NOVEL ORGANIC HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD. (KR) 2018-03-15 — — US disclosed
US-20180072753-A1 NOVEL ORGANIC HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD. (KR) 2018-03-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180072753-A1 NOVEL ORGANIC HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE COMPRISING SAME OR10J3, CRY1, NR2E3 AOC3 181/4885KCNH2 812/4885AOC2 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback